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Orogenital aphthosis, skin lesions and uveitis
characterize Behçet’s disease (BD), described by a
Turkish dermatologist in 1937.1 Vascular manifesta-
tions, although rare, may occur. Venous thrombosis
is the most frequent vascular complication. In recent
years, however, many authors have reported arterial
thrombosis or aneurysms that are the most severe
manifestations of BD because of surgical technical
difficulties or late postoperative anastomotic false
aneurysms.
For these reasons, we attempted endovascular
treatment of abdominal aneurysmal aortitis in a 37-
year-old Mediterranean man who had BD.
CASE REPORT
A 37-year-old Mediterranean man received a BD diag-
nosis in 1984 when he presented orogenital aphthosis and
deep venous thrombosis. The pathergy test (hyperactivity
of the skin to simple trauma) was positive, and the patient
was treated with oral anticoagulants (coumadin) and
colchicine thereafter. In 1996, he developed another deep
venous thrombosis, which was treated with intravenous
heparin.
During a strenuous effort in May 1997, he suffered
sudden back and abdominal pain associated with ileus.
Contrast transit excluded a diagnosis of bowel hematoma.
Abdominal contrast enhanced computed tomography
(CT) showed aortic and iliac false aneurysms (Fig. 1).
Prednisone (60 mg per day) was prescribed, and then the
patient was referred to our institution.
On examination, the patient still complained of pain on
abdominal palpation and had no signs of orogenital aphtho-
sis. Blood examination revealed neither anemia nor an
inflammatory syndrome, and C-reactive Protein was normal.
A marked pigtail aorta arteriography demonstrated an
irregular dilatation of the infrarenal aorta, a false aneurysm
at the origin of the left iliac artery and a second false
aneurysm 1 cm below the ostium of the right internal iliac
artery (Fig. 2A & 2B). Thoracic CT was normal, as was a
duplex scan (DS) of the brachiocephalic arteries.
We proposed endovascular treatment of these aortobi-
iliac false aneurysms. First, we embolized the right inter-
nal iliac artery using coils to achieve thrombosis, which a
DS confirmed 48 hours later. There were no signs of
pelvic ischemia.
Three days later, we placed a bifurcated stent below
the renal arteries through a right groin incision and left
percutaneous femoral approach. We used a thermic mem-
ory form self-expandable device, the VANGUARD endo-
prosthesis (Boston Scientific Corporation). This is made of
two components: the aortic section (22 mm diameter)
with a single limb (10 mm diameter and 153 mm total
length) inserted in an 18 F introducer. At the trailing of
the aortic section, the second controlateral limb inserts in
a short branch (9 mm diameter) through a 10 F introduc-
er. In the present case, the limb was 10 mm diameter and
100 mm long. Once in place, we expanded the nitinol
stent by gentle manual inflation with a 10-mm diameter
balloon (Ultrathin Meditech) filled with diluted contrast
medium. The procedure time was 105 minutes, with 22
minutes of fluoroscopy and an injection of 140 ml of con-
trast medium. A final angiography demonstrated throm-
bosis of the aneurysms. Recovery was uneventful, and
both DS and CT confirmed an excellent outcome (Fig. 3).
We discharged the patient from the hospital four days later
and prescribed 300 mg aspirin, 60 mg prednisone, and 1
mg of colchicine per day. He was followed up for 6
months with contrast enhanced CT and DS showing com-
plete regression of the aorta iliac false aneurysms and good
patency of the graft. Clinical examination was normal,
without any groin complication.
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DISCUSSION
BD has a peculiar geographic distribution.
Although it is rare in Western Europe (5/100,000),
it is more common in Mediterranean regions
(190/100,000) or in Japan (10/100,000), where an
association with HLA B5 has been proved.2-4 The
International Study Group for Behçet’s Disease estab-
lished five major criteria for the diagnosis: recurrent
oral or genital aphthosis, eye lesions, skin lesions, and
a positive pathergy test. BD can also involve the joints,
gastrointestinal tract or central nervous system.5
The incidence of cardiovascular complications in
BD is approximately 30%, although these complica-
tions are apparently the major cause of death, which
highlights the gravity of the condition. Therefore,
some authors include cardiovascular complications
as a sixth criterion for BD diagnosis.6 Of the vascu-
lar lesions reported, 25% affect the venous system
exclusively and 7% the arterial system exclusively —
68% of the patients with vascular involvement have
both types.7
Deep venous thrombosis (DVT), involving
peripheral veins and the inferior or superior vena
cava, is the vascular complication most usually
reported. Recurrent superficial thrombophlebitis is
an important risk factor for DVT, which we must
aggressively treat in these patients. Arterial lesions
can involve any artery with stenosis, thrombosis, and
false or true aneurysms.6 The ascending or descend-
ing thoracic aorta, the aortic arch, pulmonary artery
aneurysms, and aortic or mitral regurgitation are the
main thoracic complications associated with BD.8 In
brachiocephalic or limb arteries, both thrombosis
and aneurysms are encountered. Aortoiliac lesions
are aneurysms or false aneurysms that can rapidly
enlarge with the concomitant high risk of rupture
even if they are small. Inflammation of the aortic
wall and surrounding tissues is often observed.
The pathologic process appears to involve a vas-
culitis of the vasa vasorum with adventitial fibrosis,
destruction of the elastic and muscular fibers of the
media and intimal thickening. This explains throm-
bosis in small diameter vessels and dilatation or rup-
ture in larger vessels.9 These particular conditions
explain the technical difficulties associated with the
surgical treatment of aortoiliac lesions in BD and the
recurrent false aneurysms in anastomotic sites, which
occur in 30% to 50% of the cases. To avoid complica-
tions, you must perform anastomosis, if possible, in
macroscopically disease-free segments outside the
inflammatory area where running sutures tend to cut
through the arterial wall. Preoperative prescription of
corticosteroids is useful to reduce this inflammation
and to prevent further anastomotic false aneurysms.
Some authors propose wrapping the anastomoses,
using pledgeted sutures or performing aneurysmor-
Fig. 1. Preoperative C.T.
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rhaphy10 or simple ligation of the aneurysm when
possible.11 This case is apparently the first to report
the endoluminal grafting of aortoiliac aneurysm in
BD. Parodi, May and Miahle12-14 already proved
endovascular grafting of abdominal aortic aneurysms
was possible. Short-term results are extremely vari-
able from one device to another. If you strictly
observe the anatomical criteria, then the prognostic
outcome is good with the device that we used.15 The
VANGUARD stent is self-expandable, held in place
by a row of small barbs at the top of the prosthesis
and has a good radial force. It is a full-length stent
frame of nitinol annealed into a tubular zigzag con-
figuration. Each opposing zigzag fastens together
with a 7/0 polypropylene ligature. A polyester fabric
of low porosity covers the entire stent, except for 12
mm at the top. One of the major problems encoun-
tered with this device is a periprosthesic leak, espe-
cially when it occurs in the proximal neck because of
its aneurysmal evolution. This is particularly true in
BD because of the arterial wall fragility. We were con-
cerned that false aneurysms could appear secondarily
because the self-expanding stent exerts continuous
radial force. With precise preoperative measures and
proper sizing of the graft, however, we thought this
risk should remain low. We decided to perform this
procedure to avoid open surgery during the active
period of the disease. Although late femoral false
aneurysms may occur because of the femoral cut
down and puncture, they are easier to treat in that
location than in the aortoiliac position. Because it is
technically easier, endovascular management of this
kind of lesion has provided encouraging short-term
results in this case. However, a longer follow-up for
CT and DS is necessary to evaluate the relationship
between the endoprosthesis and the aortic wall, par-
ticularly in BD where the arterial wall is weak.
CONCLUSION
Despite its rarity in Western Europe, BD in some
cases is associated with vascular lesions, principally
through aortoiliac aneurysms when arterial involve-
ment occurs. Open surgery, although often difficult,
is the rule even with 30% to 50% of the patients
requiring second surgeries because of the occurrence
of anastomotic false aneurysms. The endovascular
approach could provide a new form of treatment,
particularly if long-term results are as positive as the
short-term results presented here.
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Fig. 3. Postoperative C.T.: thrombosis of the aortic
aneurysm and limbs of the endoprosthesis.
